These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
205 related articles for article (PubMed ID: 35617983)
1. Comprehensive analysis of expression profiles and prognosis of TRIM genes in human kidney clear cell carcinoma. Shen J; Wang R; Chen Y; Fang Z; Tang J; Yao J; Gao J; Zhou W; Chen X Aging (Albany NY); 2022 May; 14(10):4606-4617. PubMed ID: 35617983 [TBL] [Abstract][Full Text] [Related]
2. TRIM26 inhibits clear cell renal cell carcinoma progression through destabilizing ETK and thus inactivation of AKT/mTOR signaling. Zheng D; Ning J; Deng H; Ruan Y; Cheng F J Transl Med; 2024 May; 22(1):481. PubMed ID: 38773612 [TBL] [Abstract][Full Text] [Related]
3. The hsa-miR-3613-5p, a potential oncogene correlated with diagnostic and prognostic merits in kidney renal clear cell carcinoma. Ahmadi M; Najari-Hanjani P; Ghaffarnia R; Ghaderian SMH; Mousavi P; Ghafouri-Fard S Pathol Res Pract; 2023 Nov; 251():154903. PubMed ID: 37879147 [TBL] [Abstract][Full Text] [Related]
4. A microRNA-clinical prognosis model to predict the overall survival for kidney renal clear cell carcinoma. Zhan Y; Zhang R; Li C; Xu X; Zhu K; Yang Z; Zheng J; Guo Y Cancer Med; 2021 Sep; 10(17):6128-6139. PubMed ID: 34288551 [TBL] [Abstract][Full Text] [Related]
5. Tripartite-motif family genes associated with cancer stem cells affect tumor progression and can assist in the clinical prognosis of kidney renal clear cell carcinoma. Wu G; Xu Y; Li L; Li J; Ruan N; Dong J; Si Z; Xia Q; Wang Q Int J Med Sci; 2020; 17(18):2905-2916. PubMed ID: 33173411 [TBL] [Abstract][Full Text] [Related]
6. LncRNA MALAT1 modified progression of clear cell kidney carcinoma (KIRC) by regulation of miR-194-5p/ACVR2B signaling. Ye Y; Zhang F; Chen Q; Huang Z; Li M Mol Carcinog; 2019 Feb; 58(2):279-292. PubMed ID: 30334578 [TBL] [Abstract][Full Text] [Related]
7. ZEB family is a prognostic biomarker and correlates with anoikis and immune infiltration in kidney renal clear cell carcinoma. Lin S; Chen Q; Tan C; Su M; Min L; Ling L; Zhou J; Zhu T BMC Med Genomics; 2024 Jun; 17(1):153. PubMed ID: 38840097 [TBL] [Abstract][Full Text] [Related]
8. MicroRNA related prognosis biomarkers from high throughput sequencing data of kidney renal clear cell carcinoma. Huang M; Zhang T; Yao ZY; Xing C; Wu Q; Liu YW; Xing XL BMC Med Genomics; 2021 Mar; 14(1):72. PubMed ID: 33750388 [TBL] [Abstract][Full Text] [Related]
9. miR-138-5p inhibits proliferation and invasion in kidney renal clear cell carcinoma by targeting SINA3 and regulation of the Notch signaling pathway. Liu Y; Qu HC J Clin Lab Anal; 2021 Nov; 35(11):e23766. PubMed ID: 34586647 [TBL] [Abstract][Full Text] [Related]
10. Comprehensive analysis of PTEN-related ceRNA network revealing the key pathways WDFY3-AS2 - miR-21-5p/miR-221-3p/miR-222-3p - TIMP3 as potential biomarker in tumorigenesis and prognosis of kidney renal clear cell carcinoma. Zhou X; Liu G; Xu M; Ying X; Li B; Cao F; Cheng S; Xiao B; Cheng M; Liang L; Jia M; Li W; Liu J; Li Z Mol Carcinog; 2022 May; 61(5):508-523. PubMed ID: 35129856 [TBL] [Abstract][Full Text] [Related]
11. Epigenetic inactivation of ACAT1 promotes epithelial-mesenchymal transition of clear cell renal cell carcinoma. Han P; Wu S; Li L; Li D; Zhao J; Zhang H; Wang Y; Zhong X; Zhang Z; Li P; Matskova L; Zhou X Genes Genomics; 2022 Apr; 44(4):487-497. PubMed ID: 34985712 [TBL] [Abstract][Full Text] [Related]
12. Construction of circRNA-based ceRNA network to reveal the role of circRNAs in the progression and prognosis of metastatic clear cell renal cell carcinoma. Wei X; Dong Y; Chen X; Ren X; Li G; Wang Y; Wang Y; Zhang T; Wang S; Qin C; Song N Aging (Albany NY); 2020 Nov; 12(23):24184-24207. PubMed ID: 33223511 [TBL] [Abstract][Full Text] [Related]
13. Comprehensive analysis of the HOXA gene family identifies HOXA13 as a novel oncogenic gene in kidney renal clear cell carcinoma. Cui Y; Yan M; Zhang C; Xue J; Zhang Q; Ma S; Guan F; Cao W J Cancer Res Clin Oncol; 2020 Aug; 146(8):1993-2006. PubMed ID: 32444962 [TBL] [Abstract][Full Text] [Related]
14. Identification of small molecule drugs and development of a novel autophagy-related prognostic signature for kidney renal clear cell carcinoma. Xing Q; Ji C; Zhu B; Cong R; Wang Y Cancer Med; 2020 Oct; 9(19):7034-7051. PubMed ID: 32780567 [TBL] [Abstract][Full Text] [Related]
15. Comprehensive Analysis of Transcriptional Expression of hsa-mir-21 Predicted Target Genes and Immune Characteristics in Kidney Renal Clear Cell Carcinoma. Xu DM; Li M; Lin SB; Yang ZL; Xu TY; Yang JH; Yin J Int J Med Sci; 2022; 19(9):1482-1501. PubMed ID: 36035369 [No Abstract] [Full Text] [Related]
16. A Novel Gene Signature of Tripartite Motif Family for Predicting the Prognosis in Kidney Renal Clear Cell Carcinoma and Its Association With Immune Cell Infiltration. Zheng D; Zhang Y; Xia Y; Cheng F Front Oncol; 2022; 12():840410. PubMed ID: 35371994 [TBL] [Abstract][Full Text] [Related]
17. A three-microRNA signature as a diagnostic and prognostic marker in clear cell renal cancer: An In Silico analysis. Liang B; Zhao J; Wang X PLoS One; 2017; 12(6):e0180660. PubMed ID: 28662155 [TBL] [Abstract][Full Text] [Related]
18. Abnormal Expression and Prognosis Value of COG Complex Members in Kidney Renal Clear Cell Carcinoma (KIRC). Zhang Y; Lai H; Tang B Dis Markers; 2021; 2021():4570235. PubMed ID: 34539936 [TBL] [Abstract][Full Text] [Related]
19. Systematic analysis of alternative splicing signature unveils prognostic predictor for kidney renal clear cell carcinoma. Song J; Liu YD; Su J; Yuan D; Sun F; Zhu J J Cell Physiol; 2019 Dec; 234(12):22753-22764. PubMed ID: 31140607 [TBL] [Abstract][Full Text] [Related]
20. Comprehensive analysis on the expression levels and prognostic values of LOX family genes in kidney renal clear cell carcinoma. Lin S; Zheng L; Lu Y; Xia Q; Zhou P; Liu Z Cancer Med; 2020 Nov; 9(22):8624-8638. PubMed ID: 32970930 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]